CRDL is Cardiol Therapeutics Inc. (Healthcare) — a non-dividend-paying stock. Trading at $2.20. Market cap: $257M.
Stock snapshot
| Price | $2.20 |
| Market cap | $257M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About CRDL
Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.
Related non-dividend companies
Other non-dividend stocks investors research alongside CRDL. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is CRDL's current stock price?
CRDL (Cardiol Therapeutics Inc.) is currently trading at $2.20.
Does CRDL pay a dividend?
CRDL (Cardiol Therapeutics Inc.) does not currently pay a regular dividend.
Track CRDL in DiviDrip
Add CRDL to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search CRDL and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.